Access to anti-retroviral drugs, female in New Zealand
New Zealand: Access to anti-retroviral drugs, female was 80.0% in 2024. ▲ Rising
Access to anti-retroviral drugs, female in New Zealand, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
New Zealand recorded 80.0% for access to anti-retroviral drugs, female in 2024. That is the highest value across all 25 years on record.
The figure is up 3.9% on the previous year and up 23.1% over ten years.
Over the whole period, access to anti-retroviral drugs, female in New Zealand peaked at 80.0% in 2024 and was at its lowest, 30.0%, in 2000.
New Zealand ranks 57th of 141 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 25 years of available data.
Access to anti-retroviral drugs, female in New Zealand, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 30.0% | — |
| 2001 | 34.0% | +13.3% |
| 2002 | 39.0% | +14.7% |
| 2003 | 44.0% | +12.8% |
| 2004 | 48.0% | +9.1% |
| 2005 | 58.0% | +20.8% |
| 2006 | 54.0% | -6.9% |
| 2007 | 55.0% | +1.9% |
| 2008 | 56.0% | +1.8% |
| 2009 | 57.0% | +1.8% |
| 2010 | 60.0% | +5.3% |
| 2011 | 65.0% | +8.3% |
| 2012 | 63.0% | -3.1% |
| 2013 | 63.0% | +0.0% |
| 2014 | 65.0% | +3.2% |
| 2015 | 65.0% | +0.0% |
| 2016 | 66.0% | +1.5% |
| 2017 | 65.0% | -1.5% |
| 2018 | 67.0% | +3.1% |
| 2019 | 67.0% | +0.0% |
| 2020 | 69.0% | +3.0% |
| 2021 | 71.0% | +2.9% |
| 2022 | 72.0% | +1.4% |
| 2023 | 77.0% | +6.9% |
| 2024 | 80.0% | +3.9% |
New Zealand compared with similar countries
- New Zealand's 80.0% is below the median for high income countries, which is 82.0%, 98% of the median. (39 countries reporting)
- New Zealand's 80.0% is above the median for East Asia & Pacific, which is 71.0%, 1.1× the median. (15 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 47.5% | 30.0% | 58.0% | 10 |
| 2010s | 64.6% | 60.0% | 67.0% | 10 |
| 2020s | 73.8% | 69.0% | 80.0% | 5 |
Countries ranked near New Zealand
More gender data for New Zealand
- Child population (UN estimates and projections) 907.87 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.6435 % change on previous year (2030)
- Population 4,499 (2030)
- Working-age population (UN estimates and projections) 4,499 (2030)
- Population (UN estimates and projections), annual growth rate 0.7305 % change on previous year (2030)
- Age population, age 00, female, interpolated 28,751 (2025)
- Age population, age 00, male, interpolated 30,320 (2025)
- Age population, age 01, female, interpolated 29,075 (2025)
- Age population, age 01, male, interpolated 30,663 (2025)
- Age population, age 02, female, interpolated 29,141 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in New Zealand?
- Access to anti-retroviral drugs, female in New Zealand was 80.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in New Zealand?
- The highest recorded value was 80.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in New Zealand?
- The lowest recorded value was 30.0% in 2000.
- How does New Zealand rank for access to anti-retroviral drugs, female?
- New Zealand ranks 57th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in New Zealand?
- Over the last ten years it is up 23.1%. The long-run trend across the full record is rising.
- Where does this New Zealand data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.